Global medtech giant BD (Becton, Dickinson and Co.) announced today it has acquired Tepha Inc., a developer and manufacturer of proprietary resorbable polymer technology. Tepha's resorbable polymer technology platform, based on Poly 4-hydroxybutyric acid (P4HB), provides BD with growth prospects for its surgical mesh portfolio and opens opportunities in soft tissue repair, reconstruction, and regeneration, said the company in the news release. The acquisition of Tepha also provides strategic vertical integration of an important supply chain component for BD's existing Phasix Mesh products. Tepha’s polymer is used in that product to provide short-term support for soft tissue repairs, while enabling rapid tissue ingrowth and reasorption into the body over time, said BD. Tepha's GalaFlex portfolio, also based on the novel P4HB polymer, is included in the acquisition.